Ma X, Li L, Zhang L, Fu X, Li X, Wang X, . . . Zhang M. (2020). Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. Dove Medical Press.
Chicago Style (17th ed.) CitationMa X, et al. Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. Dove Medical Press, 2020.
MLA (9th ed.) CitationMa X, et al. Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.